BARICITINIB, BARICITINIB, Placebo to match LY, Baricitinib
14V-MC-JAJK
Phase 3 small_molecule active
Quick answer
BARICITINIB, BARICITINIB, Placebo to match LY, Baricitinib for Diabetes Mellitus, Type 1 is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active